2020 ESA Annual Meeting (August 3 - 6)

OOS 28 Abstract - Tumor cells and tumor-associated macrophages (TAMs): Cooperative invasive ecosystem engineers

Tuesday, August 4, 2020: 1:15 PM
Kayla Myers1, Sarah Amend2 and Kenneth Pienta2, (1)Pharmacology and Molecular Science, Johns Hopkins University, Baltimore, MD, (2)Urology, Johns Hopkins University, Baltimore, MD
Background/Question/Methods

Many aspects of cancer can be explained utilizing well-defined ecological principles. Applying these principles to cancer, cancer cells can be considered an invasive species to a healthy organ ecosystem. In their capacity as ecosystem engineers, cancer cells release cytokines that recruit monocytes to the tumor and polarize them to M2-like macrophages that promote tumor growth. Macrophages, recruited by the cancer cells, act as a secondary invasive species. The ecosystem engineering functions of M2-macrophages in turn support and stimulate cancer cell survival and proliferation.

Results/Conclusions

The cooperative ecosystem engineering of both the primary invasive species of the cancer cell and the secondary invasive species of the M2-macrophage thus creates a vicious cycle of tumor promotion. Targeting a specific aspect of this tumor-promoting ecosystem engineering, such as blocking M2-TAM differentiation or blocking efferocytosis by M2-like macrophages, may improve the response to standard-of-care anti-cancer therapies. This strategy has the potential to redirect cooperative pro-tumor ecosystem engineering towards an anti-tumor ecosystem engineering strategy.